Couldn't agree more Bedger on your argument for the existing investors. However, what puzzles me is the inability to attract new investors? They are probably one of the most (if not the most) attractive Bio company in the ASX (given their current market capitalization, their approved products and their pipeline). Why no one is paying attention to this great company?
Personally, i couldn't resist and i added more to my holding at 37 cents.
Ann: Striate re-certified under new European medical device regs, page-15
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.005(1.27%) |
Mkt cap ! $81.63M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 40.0¢ | 38.5¢ | $110.6K | 280.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 22419 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 37015 | 1 |
View Market Depth
| Last trade - 15.58pm 16/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |